India has opened the fourth round of the PLI Scheme for White Goods, inviting AC and LED manufacturers to apply from .

Registering a pharmaceutical company in India requires proper incorporation, regulatory approvals, and adherence to ...

India is keen to expand its manufacturing sector, with a focus on diversifying into newer lines of production, advancing the industrial capacity of traditional sectors like automobiles, and ...

The Ministry of Finance has released official FAQs following the 56th GST Council meeting, confirming revised GST rates and compliance clarifications. The changes come into effect from September 22, ...

India’s beauty and personal care industry is set to cross US$48 billion by 2033. The growth is driven by homegrown brands, the entry of global luxury brands, product personalization with immersive ...

The United States (US) has announced the imposition of additional tariff rates on goods from India under Executive Order (EO) 14329, signed on August 6, 2025. These custom duties come into force from ...

On May 15, 2025, India approved its sixth semiconductor manufacturing facility, a joint venture between HCL and Foxconn, as part of the India Semiconductor Mission. According to the central government ...

India-China are taking steps toward renewed economic and diplomatic engagement after years of strained relations. Discussions are underway to reopen border trade in locally manufactured goods, and ...

Foreign Exchange Management Act, 1999 (FEMA) compliance for foreign investment in India is essential for startups, exporters, and subsidiaries engaging in cross-border transactions. This guide ...

India has launched the Electronics Component Manufacturing Scheme (ECMS), with applications opening on May 1, 2025. The incentive distribution will be carried out by the central government on a “first ...

The tariff structure imposed by the US on Indian goods varies across sectors, with some industries facing significantly high import duties. Indian dairy exports, for example, face exceptionally high ...

US President Donald Trump has issued a new executive order mandating pharmaceutical companies to reduce the prices of drugs sold in the United States. The directive aims to align drug prices in the US ...